Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an o...
Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Approximately 25% of kidney transplant recipients develop de novo anti-HLA donor-specific antibodies (dnDSA) leading to acute antibody-mediated rejection (ABMR) in 30% of patients. Preemptive therapeutic strategies are not available.
We conducted a prospective observational study including 11 kidney transplant recipients. Inclusion criteria were...
Alternative Titles
Full title
Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_1914148898
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1914148898
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0178572
